132 related articles for article (PubMed ID: 26119998)
41. Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
Mishra R; Watanabe T; Kimura MT; Koshikawa N; Ikeda M; Uekusa S; Kawashima H; Wang X; Igarashi J; Choudhury D; Grandori C; Kemp CJ; Ohira M; Verma NK; Kobayashi Y; Takeuchi J; Koshinaga T; Nemoto N; Fukuda N; Soma M; Kusafuka T; Fujiwara K; Nagase H
Cancer Sci; 2015 Apr; 106(4):421-9. PubMed ID: 25611295
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Wang X; Nagase H; Watanabe T; Nobusue H; Suzuki T; Asami Y; Shinojima Y; Kawashima H; Takagi K; Mishra R; Igarashi J; Kimura M; Takayama T; Fukuda N; Sugiyama H
Cancer Sci; 2010 Mar; 101(3):759-66. PubMed ID: 20085585
[TBL] [Abstract][Full Text] [Related]
43. Single position substitution of hairpin pyrrole-imidazole polyamides imparts distinct DNA-binding profiles across the human genome.
Finn PB; Bhimsaria D; Ali A; Eguchi A; Ansari AZ; Dervan PB
PLoS One; 2020; 15(12):e0243905. PubMed ID: 33351840
[TBL] [Abstract][Full Text] [Related]
44. Interference with DNA repair after ionizing radiation by a pyrrole-imidazole polyamide.
Diaz-Perez S; Kane N; Kurmis AA; Yang F; Kummer NT; Dervan PB; Nickols NG
PLoS One; 2018; 13(5):e0196803. PubMed ID: 29715291
[TBL] [Abstract][Full Text] [Related]
45. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.
Saito K; Fukuda N; Shinohara K; Masuhiro Y; Hanazawa S; Matsuda H; Fujiwara K; Ueno T; Soma M
Int J Biochem Cell Biol; 2015 Sep; 66():112-20. PubMed ID: 26222185
[TBL] [Abstract][Full Text] [Related]
46. Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture.
Best TP; Edelson BS; Nickols NG; Dervan PB
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12063-8. PubMed ID: 14519850
[TBL] [Abstract][Full Text] [Related]
47. Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth.
Obinata D; Ito A; Fujiwara K; Takayama K; Ashikari D; Murata Y; Yamaguchi K; Urano T; Fujimura T; Fukuda N; Soma M; Watanabe T; Nagase H; Inoue S; Takahashi S
Cancer Sci; 2014 Oct; 105(10):1272-8. PubMed ID: 25088707
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
Matsuda H; Fukuda N; Ueno T; Katakawa M; Wang X; Watanabe T; Matsui S; Aoyama T; Saito K; Bando T; Matsumoto Y; Nagase H; Matsumoto K; Sugiyama H
Kidney Int; 2011 Jan; 79(1):46-56. PubMed ID: 20861821
[TBL] [Abstract][Full Text] [Related]
49. Progress and prospects of pyrrole-imidazole polyamide-fluorophore conjugates as sequence-selective DNA probes.
Vaijayanthi T; Bando T; Pandian GN; Sugiyama H
Chembiochem; 2012 Oct; 13(15):2170-85. PubMed ID: 23023993
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
51. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
52. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
Hu Q; Bhattacharya C; Maity SN
J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
[TBL] [Abstract][Full Text] [Related]
53. Sequence-specific DNA binding Pyrrole-imidazole polyamides and their applications.
Kawamoto Y; Bando T; Sugiyama H
Bioorg Med Chem; 2018 May; 26(8):1393-1411. PubMed ID: 29439914
[TBL] [Abstract][Full Text] [Related]
54. Effects of Pyrrole-Imidazole Polyamides Targeting Human TGF-β1 on the Malignant Phenotypes of Liver Cancer Cells.
Takagi K; Midorikawa Y; Takayama T; Abe H; Fujiwara K; Soma M; Nagase H; Miki T; Fukuda N
Molecules; 2020 Jun; 25(12):. PubMed ID: 32585841
[TBL] [Abstract][Full Text] [Related]
55. A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.
Yao EH; Fukuda N; Ueno T; Matsuda H; Nagase H; Matsumoto Y; Sugiyama H; Matsumoto K
Cardiovasc Res; 2009 Mar; 81(4):797-804. PubMed ID: 19098300
[TBL] [Abstract][Full Text] [Related]
56. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
Yun J; Tomida A; Andoh T; Tsuruo T
J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.
Zhang M; Liang J; Jiang SK; Xu L; Wu YL; Awadasseid A; Zhao XY; Xiong XQ; Sugiyama H; Zhang W
Eur J Med Chem; 2020 Dec; 207():112704. PubMed ID: 32866755
[TBL] [Abstract][Full Text] [Related]
58. An investigation of targeted inhibition of transcription factor activity with pyrrole imidazole polyamide (PA) in chronic myeloid leukemia (CML) blast crisis cells.
Hayatigolkhatmi K; Padroni G; Su W; Fang L; Gómez-Castañeda E; Hsieh YC; Jackson L; Pellicano F; Burley GA; Jørgensen HG
Bioorg Med Chem Lett; 2019 Sep; 29(18):2622-2625. PubMed ID: 31378570
[TBL] [Abstract][Full Text] [Related]
59. Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression.
Bhosle J; Kiakos K; Porter AC; Wu J; Makris A; Hartley JA; Hochhauser D
Mol Cancer Ther; 2013 Dec; 12(12):2897-908. PubMed ID: 24092808
[TBL] [Abstract][Full Text] [Related]
60. Development of pyrrole-imidazole polyamide targeting fc receptor common gamma chain for the treatment of immune-complex related renal disease.
Kajiwara M; Ueno T; Fukuda N; Matsuda H; Shimokawa T; Kitai M; Tsunemi A; Fuke Y; Fujita T; Matsumoto K; Matsumoto Y; Ra C; Soma M
Biol Pharm Bull; 2012; 35(11):2028-35. PubMed ID: 22971693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
